Point72 Asset Management
XGN icon

Point72 Asset Management’s Exagen XGN Stock Holding History

Point72 Asset Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.3K Sell
19,436
-185,764
-91% -$718K ﹤0.01% 3652
2025
Q4 		$1.25M Buy
+205,200
New +$1.87M ﹤0.01% 2753
2025
Q3 		– Sell
-136,380
Closed -$952K – 2745
2025
Q2 		$952K Buy
+136,380
New +$829K ﹤0.01% 1577

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Point72 Asset Management's XGN Position: Q1 2026 in Review

Point72 Asset Management reduced its Exagen (XGN) stake by 91% in Q1 2026, selling an estimated $718K and leaving 19,436 shares worth $58.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Point72 Asset Management first reported a position in XGN in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Point72 Asset Management held 19,436 shares of Exagen worth $58.3K as of Q1 2026.
  • Point72 Asset Management sold 185,764 Exagen shares in Q1 2026, an estimated $718K.
  • Exagen made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3652 holding.
  • Point72 Asset Management first reported a position in Exagen in Q2 2025 and has held it in 3 quarters since.
  • Point72 Asset Management's Exagen position peaked at $1.25M in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.